These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 30927924)

  • 1. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
    Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression.
    Sun G; Li Z; He Z; Wang W; Wang S; Zhang X; Cao J; Xu P; Wang H; Huang X; Xia Y; Lv J; Xuan Z; Jiang T; Fang L; Yang J; Zhang D; Xu H; Xu Z
    J Exp Clin Cancer Res; 2020 Nov; 39(1):246. PubMed ID: 33198772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
    Zhang Q; Miao Y; Fu Q; Hu H; Chen H; Zeng A; Jin Y; Jiang Y; Qian L; Wu L; Xu L; Wang G; Qiu L; Huang X; Xia Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):713-720. PubMed ID: 32253030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0017274 acts on miR-637/CDX2 axis to facilitate cisplatin resistance in gastric cancer.
    Xu B; Guo J; Chen M
    Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1105-1115. PubMed ID: 35748299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circ_0001017 Sensitizes Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy by the miR-543/PHLPP2 Axis.
    Zhang J; Zha W; Qian C; Ding A; Mao Z
    Biochem Genet; 2022 Apr; 60(2):558-575. PubMed ID: 34313883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.
    Peng L; Sang H; Wei S; Li Y; Jin D; Zhu X; Li X; Dang Y; Zhang G
    Mol Cancer; 2020 Nov; 19(1):156. PubMed ID: 33153478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer.
    Fei Y; Cao D; Li Y; Wang Z; Dong R; Zhu M; Gao P; Wang X; Cai J; Zuo X
    J Nanobiotechnology; 2024 Aug; 22(1):519. PubMed ID: 39210348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity.
    Xu Y; Jiang T; Wu C; Zhang Y
    Biotechnol Lett; 2020 Jul; 42(7):1123-1135. PubMed ID: 32170433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
    Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
    Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation.
    Li H; Lin R; Zhang Y; Zhu Y; Huang S; Lan J; Lu N; Xie C; He S; Zhang W
    Mol Cancer; 2024 Jan; 23(1):5. PubMed ID: 38184597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p.
    Liu YY; Zhang LY; Du WZ
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31793989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircAKT3 promotes cell proliferation, survival and glutamine metabolism of gastric cancer by activating SLC1A5 expression via targeting miR-515-5p.
    Li F; Zhang L; Sun Q
    Histol Histopathol; 2022 Mar; 37(3):227-241. PubMed ID: 34850965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced expression of circular RNA circ-DCAF6 predicts adverse prognosis and promotes cell progression via sponging miR-1231 and miR-1256 in gastric cancer.
    Wu L; Liu D; Yang Y
    Exp Mol Pathol; 2019 Oct; 110():104273. PubMed ID: 31226266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway.
    Zhang Z; Yu X; Zhou B; Zhang J; Chang J
    Biomed Res Int; 2020; 2020():5103272. PubMed ID: 32855967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/KAT6B axis.
    Cheng W; Luan P; Jin X
    Anticancer Drugs; 2023 Jan; 34(1):126-134. PubMed ID: 36206113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression.
    Luo Z; Rong Z; Zhang J; Zhu Z; Yu Z; Li T; Fu Z; Qiu Z; Huang C
    Mol Cancer; 2020 May; 19(1):86. PubMed ID: 32386516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression.
    Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J
    Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p.
    Huang XX; Zhang Q; Hu H; Jin Y; Zeng AL; Xia YB; Xu L
    J Cell Biochem; 2020 Jan; ():. PubMed ID: 31898357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.